» Articles » PMID: 37686757

Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency

Overview
Journal Nutrients
Date 2023 Sep 9
PMID 37686757
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Studies indicate a high prevalence of vitamin D deficiency in both the general population and at-risk groups. Given the association between vitamin D deficiency and various diseases, addressing this concern becomes crucial, especially in situations where routine monitoring is challenging.

Materials And Methods: A systematic literature review of the current knowledge on vitamin D dosing in diverse at-risk populations and the application of the findings to a broader clinical perspective.

Results: The reviewed studies revealed a high prevalence of vitamin D deficiency among patients with musculoskeletal disorders, systemic connective tissue diseases, corticosteroid use, endocrine and metabolic conditions, malabsorption syndromes, obesity, chronic kidney disease, cancer, and central nervous system diseases. Vitamin D deficiency was often more severe compared to the general population. Higher dosages of vitamin D beyond the recommended levels for the general population were shown to be effective in improving vitamin D status in these at-risk individuals. Additionally, some studies suggested a potential link between intermittent vitamin D administration and improved adherence.

Conclusion: Simplified dosing could empower clinicians to address vitamin D deficiency, particularly in high-risk populations, even without routine monitoring. Further research is needed to establish the optimal dosing regimens for specific at-risk populations.

Citing Articles

Vitamin D Supplementation: Practical Advice in Different Clinical Settings.

Bendotti G, Biamonte E, Leporati P, Goglia U, Ruggeri R, Gallo M Nutrients. 2025; 17(5).

PMID: 40077652 PMC: 11901608. DOI: 10.3390/nu17050783.


A cohort study of serum 25-hydroxyvitamin D levels and the risk of hyperlipidaemia in adults.

Liu Z, Liu S, Yao X, Wang C, Song Y, Bi Y Front Nutr. 2025; 11:1492621.

PMID: 39925969 PMC: 11802281. DOI: 10.3389/fnut.2024.1492621.


Vitamin D Supplementation in Critically Ill-Narrative Review.

Saric L, Domazet Bugarin J, Dosenovic S Nutrients. 2025; 17(1.

PMID: 39796590 PMC: 11723408. DOI: 10.3390/nu17010156.


The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential.

Johnson C, Stevens C, Bennett M, Litch A, Rodrigue E, Quintanilla M Nutrients. 2024; 16(23).

PMID: 39683402 PMC: 11643663. DOI: 10.3390/nu16234007.


Assessing the Impact of Vitamin D Supplementation on Respiratory Infections in Children and Adolescents: A Cross-Sectional Study.

Tanase E, Marusca L, Horhat F, Susan M, Susan R, Horhat R Nutrients. 2024; 16(22).

PMID: 39599738 PMC: 11597694. DOI: 10.3390/nu16223953.


References
1.
Raftery T, Martineau A, Greiller C, Ghosh S, McNamara D, Bennett K . Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study. United European Gastroenterol J. 2015; 3(3):294-302. PMC: 4480538. DOI: 10.1177/2050640615572176. View

2.
Pludowski P, Kos-Kudla B, Walczak M, Fal A, Zozulinska-Ziolkiewicz D, Sieroszewski P . Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023; 15(3). PMC: 9920487. DOI: 10.3390/nu15030695. View

3.
Gregson C, Armstrong D, Bowden J, Cooper C, Edwards J, Gittoes N . UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2022; 17(1):58. PMC: 8979902. DOI: 10.1007/s11657-022-01061-5. View

4.
Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R . Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study. Nutrients. 2020; 12(6). PMC: 7352201. DOI: 10.3390/nu12061553. View

5.
Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Medart L . Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant. 2013; 28(7):1779-86. DOI: 10.1093/ndt/gft001. View